efavirenz has been researched along with Stroke in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nordling, L | 1 |
Bertrand, L; Dygert, L; Toborek, M | 1 |
2 other study(ies) available for efavirenz and Stroke
Article | Year |
---|---|
How the genomics revolution could finally help Africa.
Topics: Africa; Alkynes; Anti-HIV Agents; Apolipoprotein L1; Apolipoproteins; Benzoxazines; Black People; Charities; Cyclopropanes; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Genetics, Medical; Genome-Wide Association Study; Genomics; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Kidney Diseases; Lipoproteins, HDL; National Institutes of Health (U.S.); Neoplasms; Oxazines; Piperazines; Polymorphism, Single Nucleotide; Precision Medicine; Public Health; Pyridones; Reverse Transcriptase Inhibitors; Stroke; Trypanosomiasis, African; United States; White People | 2017 |
Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity.
Topics: Alkynes; Animals; Benzoxazines; Blood-Brain Barrier; Cell Line; Cyclopropanes; HIV Infections; Humans; Male; Mice; Severity of Illness Index; Stroke | 2016 |